Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20543616 | 0.92 | MMP8 (0.52) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL17604992 | 0.91 | ALDH1A1 (0.63) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL18926557 | 0.91 | EPHX2 (0.52) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL2422171 | 0.89 | MMP8 (0.52) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL5475645 | 0.89 | MMP8 (0.52) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL2672677 | 0.89 | MMP8 (0.56) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL8007724 | 0.89 | MMP8 (0.52) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL2672357 | 0.87 | ALDH1A1 (0.60) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL165382 | 0.87 | MMP8 (0.76) | MMP8ALDH1A1TP53TDP1MAPK1 | |
| SCHEMBL6714650 | 0.85 | HTR2A (0.55) | MMP8ALDH1A1TP53TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250025855-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | ExxonMobil Technology and Engineering Company | 2025-01-23 | — | — | US | disclosed |
| US-20250025854-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | ExxonMobil Technology and Engineering Company | 2025-01-23 | — | — | US | disclosed |
| US-12161990-B2 | EMM-41 composition, methods of making and uses thereof | ExxonMobil Technology and Engineering Company (US) | 2024-12-10 | — | — | US | disclosed |
| US-20220023827-A1 | EMM-41 Composition, Methods of Making and Uses Thereof | EXXONMOBIL RES & ENG CO (US) | 2022-01-27 | — | — | US | disclosed |
| US-20220023827-A1 | EMM-41 Composition, Methods of Making and Uses Thereof | EXXONMOBIL RES & ENG CO (US) | 2022-01-27 | — | — | US | disclosed |
| EP-3383796-B1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2020-09-16 | — | — | EP | disclosed |
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RES & ENG CO (US) | 2019-07-18 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2019-04-09 | — | — | US | disclosed |
| EP-3383796-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | Exxonmobil Research And Engineering Company (US) | 2018-10-10 | — | — | EP | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY | 2017-06-08 | — | — | US | disclosed |
| WO-2017095705-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) | 2017-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220023827-A1 | EMM-41 Composition, Methods of Making and Uses Thereof | CD14, CD68, MASP2 | MMP8 88/4885ALDH1A1 4549/4885TP53 721/4885 |
| US-20250025855-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | CD14, CD68, MASP2 | MMP8 88/4885ALDH1A1 4549/4885TP53 721/4885 |
| US-12161990-B2 | EMM-41 composition, methods of making and uses thereof | CD14, CD68, MASP2 | MMP8 88/4885ALDH1A1 4549/4885TP53 721/4885 |
| US-10597300-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | MMP8 437/4885ALDH1A1 4842/4885TP53 544/4885 |
| US-10252918-B2 | EMM-28, a novel synthetic crystalline material, its preparation and use | CD14, ERG28, DAP3 | MMP8 437/4885ALDH1A1 4842/4885TP53 544/4885 |
| US-20250025854-A1 | EMM-41 COMPOSITION, METHODS OF MAKING AND USES THEREOF | CD14, CD68, MASP2 | MMP8 88/4885ALDH1A1 4549/4885TP53 721/4885 |
| US-20170158521-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | MMP8 437/4885ALDH1A1 4842/4885TP53 544/4885 |
| US-20190218106-A1 | EMM-28, A NOVEL SYNTHETIC CRYSTALLINE MATERIAL, ITS PREPARATION AND USE | CD14, ERG28, DAP3 | MMP8 437/4885ALDH1A1 4842/4885TP53 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.